Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cholecystolithiasis × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 NET 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 358 Carcinoid Tumor 42 Gastro-enteropancreatic neuroendocrine tumor 38 Neoplasms 32 Carcinoma, Neuroendocrine 30 Adenoma, Islet Cell 24 Neoplasm Metastasis 20 Colorectal Neoplasms 20 Pancreatic Neoplasms 19 Pheochromocytoma 18 Paraganglioma 17 Gastrointestinal Neoplasms 14 Carcinoma 14 Stomach Neoplasms 13 Sarcoma 13 Carcinoma, Hepatocellular 13 Breast Neoplasms 12 Thyroid Neoplasms 11 Prostatic Neoplasms 11 Neuroblastoma 11 Small Cell Lung Carcinoma 9 Lung Neoplasms 9 Cholangiocarcinoma 9 Carcinoma, Non-Small-Cell Lung 9 Serotonin Syndrome 8 Digestive System Neoplasms 8 Carcinoma, Renal Cell 8 Brain Neoplasms 8 Somatostatinoma 7 Neuroectodermal Tumors, Primitive 7

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04735198 2025-05-20

TNE-IDC-COLE

Hospital Universitari de Bellvitge

Phase NA Recruiting

Neuroendocrine Tumors, Cholecystolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡